Who backs Indapta Therapeutics?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Cancer Prevention and Research Institute of Texas | — |
| Leaps by Bayer | — |
| Leerink Partners | — |
| Lonza Group | — |
| Myeloma Investment Fund | — |
| National Cancer Institute | — |
| Pontifax Venture Capital | — |
| Red Cedar Ventures | — |
| Silicon Valley Bank | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Indapta Therapeutics
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Indapta Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.